Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

SiteOne Therapeutics is a clinical-stage biopharmaceutical company developing therapeutics for the treatment of hypersensitivity disorders such as chronic cough, itch and pain. Our drug candidates are exquisitely selective inhibitors of voltage-gated sodium ion channels that are under investigation for the treatment of multiple neurogenic diseases by systemic and local routes of administration.

List your booth number for exhibitions, ask us